The company, which was spun-out of Seoul National University in 2004, has developed a target-selective tissue-delivery technology that enables antibody ... on a unique peptide-delivery carrier ...

Primrose’s unique and broad capabilities in nucleic acid engineering ... from small-interfering RNA and other oligonucleotides to peptide- and protein-based therapies, depend on high-quality ...

ImmunoPrecise Antibodies Ltd. (IPA ... IPA applied rational genetic engineering to enhance peptide longevity and performance in early-stage studies. Additionally, IPA has optimized its GLP-1 ...